Upload Avatar (500 x 500)
Zhiyong Wang
wzy0809@zju.edu.cn
English, Chinese
Zhejiang
Zhejiang University
Medical
  • PhD: Sichuan University, West China School of Stomatology
  • Selected for the Overseas High-Level Talent Youth Project
  • Received the 2017 IADR China Young Scholar Award
  • Current - Zhejiang University, Researcher and Doctoral Supervisor
  • 12 years - Team of Prof. J.Silvio Gutkind, USA, Associate Researcher
  • IADR China Young Scholar Award (2017)
Molecular Cell Biology
Tumor Immunology
Molecular Mechanisms of Oral Diseases
  • CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma, Wang S, Wu Z, Zhu S, Wan S, Zhang M, Zhang B, Yang Q, Xiao Y, Li H, Mao L, Wang Z, Gutkind JS, 2023
  • Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC, Saddawi-Konefka R, O’Farrell A, Faraji F, Clubb L, Allevato M, Jensen S, Yung B, Wang Z, Wu V, Anang N, Msari R, Schokrpur S, Pietryga I, Molinolo A, Mesirov J, Simon A, Fox B, Bui J, Sharabi A, Cohen E, Califano J, Gutkind JS, 2022
  • Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy, Hingorani D, Allevato M, Camargo M, Lesperance J, Quraishi M, Aguilera J, Franiak-Pietryga I, Scanderbeg D, Wang Z, Molinolo A, Alvarado D, Sharabi A, Bui J, Cohen E, Adams S, Gutkind JS, Advani S, 2022
  • Microneedle-mediated intratumoral delivery of anti-CTLA-4 promotes cDC1-dependent eradication of oral squamous cell carcinoma with limited irAEs, Gilardi M, Saddawi-Konefka R, Wu V, Lopez-Ramirez M, Wang Z, Soto F, Ramms D, Proietto M, Mikulski Z, Miki H, Sharabi A, Kupor D, Rueda R, Hollern D, Wang J, Gutkind JS, 2022
  • A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity, Swaney D, Ramms D, Wang Z, Park J, Goto Y, Soucheray M, Bhola N, Kim K, Zheng F, McGregor M, Herrington K, O’Keefe R, Jin N, VanLandingham N, Foussard H, Dollen J, Bouhaddou M, Jimenez-Morales D, Obernier K, Kreisberg J, Kim M, Johnson D, Jura N, Grandis J, Gutkind JS, Ideker T, Krogan N, 2021
  • EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1, Ando T, Arang A, Wang Z, Costea D, Feng X, Goto Y, Izumi H, Gilardi M, Ando K, Gutkind JS, 2021
  • Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer, Wang Z, Goto Y, Allevato M, Wu V, Saddawi-Konefka R, Gilardi M, Alvarado D, Yung B, O’Farrell A, Molinolo A, Duvvuri U, Grandis J, Califano J, Cohen E, Gutkind JS, 2021
  • Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions, Gutkind JS, Molinolo A, Wu X, Wang Z, Nachmanson D, Harismendy O, Alexandrov L, Wuertz B, Ondrey F, Laronde D, Rock L, Rosin M, Coffey C, Butler V, Bengtson L, Hsu C, Bauman J, Hewitt S, Cohen E, Chow S, Lippman S, Szabo E, 2021
  • Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis, Yoon H, Tang C, Banerjee S, Yebra M, Noh S, Burgoyne A, Torre J, Siena M, Liu M, Klug L, Choi Y, Hosseini M, Delgado A, Wang Z, French R, Lowy A, DeMatteo R, Heinrich M, Molinolo A, Gutkind JS, Harismendy O, Sicklick J, 2021
  • Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK–YAP signaling axis, Goto Y, Ando T, Izumi H, Feng X, Arang N, Gilardi M, Wang Z, Ando K, Gutkind JS, 2020
  • Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas, Gilardi M, Wang Z, Proietto M, Chillà A, Calleja-Valera J, Goto Y, Vanoni M, Janes M, Mikulski Z, Gualberto A, Molinolo A, Ferrara N, Burrows F, Gutkind JS, 2020
  • Pathway-specific genome editing of PI3K/mTOR tumor suppressor genes reveals that PTEN loss contributes to cetuximab resistance in head and neck cancer, Izumi H, Wang Z, Goto Y, Ando T, Wu X, Zhang X, Li H, Johnson D, Grandis JR, Gutkind JS, 2020
  • YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity, Yuan Y, Park J, Feng A, Awasthi P, Wang Z, Chen Q, Iglesias-Bartolome R, 2020
  • Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling, Stratman A, Farrelly O, Mikelis C, Miller M, Wang Z, Pham V, Davis A, Burns M, Pezoa S, Castranova D, Yano J, Kilts T, Davis G, Gutkind JS, Weinstein B, 2020
  • ZBP1 (DAI/DLM-1) promotes osteogenic differentiation while inhibiting adipogenic differentiation in mesenchymal stem cells through a positive feedback loop of Wnt/β-catenin signaling, Zhao X, Xie L, Wang Z, Wang J, Xu H, Han X, Bai D, Deng P, 2020
  • Syngeneic animal model of tobacco-associated oral cancer reveals the activity of in situ anti-CTLA-4, Wang Z, Wu V, Allevato A, Gilardi M, He Y, Callejas-Valera J, Vitale-Cross l, Martin D, Amornphimoltham P, Mcdermott J, Yung B, Goto Y, Molinolo A, Sharabi A, Cohen E, Chen Q, Lyons G, Alexandrov L, Gutkind JS, 2019
  • 4E-BP1 is a head and neck cancer tumor suppressor protein reactivated by mTOR inhibition, Wang Z, Feng X, Molinolo A, Martin D, Vitale-Cross L, Nohata N, Ando M, Wahba A, Amornphimoltham P, Wu X, Gilardi M, Allevato M, Wu V, Steffen D, Tofilon P, Sonenberg N, Califano J, Chen Q, Lippman S, Gutkind JS, 2019
  • A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK, Feng X, Arang N, Rigiracciolo D, Lee J, Yeerna H, Wang Z, Lubrano S, Kishore A, Pachter J, Konig G, Maggiolini M, KostenisE, Schlaepfer D, Tamayo P, Chen Q, Ruppin E, Gutkind JS, 2019
  • Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy, Sahu A, Lee J, Wang Z, Zhang G, Iglesias-Bartolomé R, Tian T, Wei, Z, Miao B, Nair N, Ponomarova O, Friedman A, Amzallag A, Moll T, Kasumova G, Greninger P, Egan R, Damon E, Frederick D, Jerby-Arnon L, Wagner A, Cheng K, Park S, Robinson W, Gardner K, Boland G, Hannenhalli S, Herlyn M, Benes C, Flaherty K, Luo J, Gutkind JS, Ruppin E, 2019
  • Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial, Day T, Shirai K, O'Brien P, Matheus M, Godwin K, Sood A, Kompelli A, Vick J, Martin D, Vitale-Cross L, Callejas-Varela J, Wang Z, Wu X, Harismendy O, Molinolo A, Lippman S, Waes C, Szabo E, Gutkind JS, 2019
  • Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells, Wu X, Yeerna H, Goto Y, Ando T, Wu V, Zhang X, Wang Z, Amornphimoltham P, Murphy AN, Tamayo P, Chen Q, Lippman SM, Gutkind JS, 2019
  • Dual-functional guanosine-based hydrogel integrating localized delivery and anticancer activities for cancer therapy, Zhao H, Feng H, Liu J, Tang F, Du Y, Ji N, Xie L, Zhao X, Wang Z, Chen Q, 2019
  • Assembly and activation of the Hippo signalome by FAT1 tumor suppressor, Martin D, Degese MS, Vitale-Cross L, Iglesias-Bartolome R, Valera JC, Wang Z, Feng X, Yeerna H, Vadmal V, Moroishi T, Thorne RF, Zaida M, Siegele B, Cheong SC, Molinolo AA, Samuels Y, Tamayo P, Guan KL, Lippman SM, Lyons JG, Gutkind JS, 2018
  • mTOR Co-targeting Strategies for Head and Neck Cancer Therapy, Wang Z, Valera J, Zhao X, Chen Q, Gutkind JS, 2017
  • Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study, Xu H, Jin X, Yuan Y, Deng P, Jiang L, Zeng X, Li X, Wang Z, Chen Q, 2017
  • LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS, Yuan Y, Xie X, Jiang Y, Wei Z, Wang P, Chen F, Li X, Sun C, Zhao H, Jiang L, Zhou Y, Dan H, Feng M, Liu R, Wang Z, Chen Q, 2017
  • Roles of FGFR in oral carcinogenesis, Xie X, Wang Z, Chen F, Yuan Y, Wang J, Liu R, Chen Q, 2016
  • Emerging Cancer Biomarkers for HNSCC Detection and Therapeutic Intervention, Patel V, Wang Z, Chen Q, Rusling JF, Molinolo AA, Gutkind JS, 2016
  • A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers
Cell Biology Molecular Biology Signal Transduction Cancer Immunotherapy Oral Diseases Tumor Microenvironment Clinical Samples Animal Models Drug Development

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.